141 related articles for article (PubMed ID: 26400557)
21. Harmonizing SUVs in multicentre trials when using different generation PET systems: prospective validation in non-small cell lung cancer patients.
Lasnon C; Desmonts C; Quak E; Gervais R; Do P; Dubos-Arvis C; Aide N
Eur J Nucl Med Mol Imaging; 2013 Jul; 40(7):985-96. PubMed ID: 23564036
[TBL] [Abstract][Full Text] [Related]
22. Energy-based scatter estimation in clinical PET.
Hamill JJ; Cabello J; Surti S; Karp JS
Med Phys; 2024 Jan; 51(1):54-69. PubMed ID: 37956261
[TBL] [Abstract][Full Text] [Related]
23. Spatial resolution and image qualities of Zr-89 on Siemens Biograph TruePoint PET/CT.
Lee YS; Kim JS; Kim JY; Kim BI; Lim SM; Kim HJ
Cancer Biother Radiopharm; 2015 Feb; 30(1):27-32. PubMed ID: 25549151
[TBL] [Abstract][Full Text] [Related]
24. Hybrid [¹⁸F]-FDG PET/MRI including non-Gaussian diffusion-weighted imaging (DWI): preliminary results in non-small cell lung cancer (NSCLC).
Heusch P; Köhler J; Wittsack HJ; Heusner TA; Buchbender C; Poeppel TD; Nensa F; Wetter A; Gauler T; Hartung V; Lanzman RS
Eur J Radiol; 2013 Nov; 82(11):2055-60. PubMed ID: 23830904
[TBL] [Abstract][Full Text] [Related]
25. Noise considerations for PET quantification using maximum and peak standardized uptake value.
Lodge MA; Chaudhry MA; Wahl RL
J Nucl Med; 2012 Jul; 53(7):1041-7. PubMed ID: 22627001
[TBL] [Abstract][Full Text] [Related]
26. Multicentre analysis of PET SUV using vendor-neutral software: the Japanese Harmonization Technology (J-Hart) study.
Tsutsui Y; Daisaki H; Akamatsu G; Umeda T; Ogawa M; Kajiwara H; Kawase S; Sakurai M; Nishida H; Magota K; Mori K; Sasaki M;
EJNMMI Res; 2018 Aug; 8(1):83. PubMed ID: 30128776
[TBL] [Abstract][Full Text] [Related]
27. Phantom study of the impact of reconstruction parameters on the detection of mini- and micro-volume lesions with a low-dose PET/CT acquisition protocol.
Ferretti A; Bellan E; Gava M; Chondrogiannis S; Massaro A; Nibale O; Rubello D
Eur J Radiol; 2012 Nov; 81(11):3363-70. PubMed ID: 22613508
[TBL] [Abstract][Full Text] [Related]
28. Optimization of PET/CT image quality using the GE 'Sharp IR' point-spread function reconstruction algorithm.
Vennart NJ; Bird N; Buscombe J; Cheow HK; Nowosinska E; Heard S
Nucl Med Commun; 2017 Jun; 38(6):471-479. PubMed ID: 28394818
[TBL] [Abstract][Full Text] [Related]
29. Body surface area adapted iopromide 300 mg/ml versus 370 mg/ml contrast medium injection protocol: influence on quantitative and clinical assessment in combined PET/CT.
Verburg FA; Apitzsch J; Lensing C; Kuhl CK; Pietsch H; Mottaghy FM; Behrendt FF
Eur J Radiol; 2013 Dec; 82(12):2348-52. PubMed ID: 24113432
[TBL] [Abstract][Full Text] [Related]
30. Impact of PET/CT image reconstruction methods and liver uptake normalization strategies on quantitative image analysis.
Kuhnert G; Boellaard R; Sterzer S; Kahraman D; Scheffler M; Wolf J; Dietlein M; Drzezga A; Kobe C
Eur J Nucl Med Mol Imaging; 2016 Feb; 43(2):249-258. PubMed ID: 26280981
[TBL] [Abstract][Full Text] [Related]
31. 18F-FDG PET definition of gross tumor volume for radiotherapy of non-small cell lung cancer: is a single standardized uptake value threshold approach appropriate?
Biehl KJ; Kong FM; Dehdashti F; Jin JY; Mutic S; El Naqa I; Siegel BA; Bradley JD
J Nucl Med; 2006 Nov; 47(11):1808-12. PubMed ID: 17079814
[TBL] [Abstract][Full Text] [Related]
32. Adrenal masses in patients with cancer: PET/CT characterization with combined CT histogram and standardized uptake value PET analysis.
Perri M; Erba P; Volterrani D; Guidoccio F; Lazzeri E; Caramella D; Mariani G
AJR Am J Roentgenol; 2011 Jul; 197(1):209-16. PubMed ID: 21701032
[TBL] [Abstract][Full Text] [Related]
33. Multicenter quantitative
Vosoughi H; Momennezhad M; Emami F; Hajizadeh M; Rahmim A; Geramifar P
Quant Imaging Med Surg; 2023 Apr; 13(4):2218-2233. PubMed ID: 37064407
[TBL] [Abstract][Full Text] [Related]
34. Does partial volume corrected maximum SUV based on count recovery coefficient in 3D-PET/CT correlate with clinical aggressiveness of non-Hodgkin's lymphoma?
Tsujikawa T; Otsuka H; Morita N; Saegusa H; Kobayashi M; Okazawa H; Nishitani H
Ann Nucl Med; 2008 Jan; 22(1):23-30. PubMed ID: 18250984
[TBL] [Abstract][Full Text] [Related]
35. Harmonization of PET image reconstruction parameters in simultaneous PET/MRI.
Laforest R; Khalighi M; Natsuaki Y; Rajagopal A; Chandramohan D; Byrd D; An H; Larson P; James SS; Sunderland JJ; Kinahan PE; Hope TA
EJNMMI Phys; 2021 Nov; 8(1):75. PubMed ID: 34739621
[TBL] [Abstract][Full Text] [Related]
36. Assessment of interobserver reproducibility in quantitative 18F-FDG PET and CT measurements of tumor response to therapy.
Jacene HA; Leboulleux S; Baba S; Chatzifotiadis D; Goudarzi B; Teytelbaum O; Horton KM; Kamel I; Macura KJ; Tsai HL; Kowalski J; Wahl RL
J Nucl Med; 2009 Nov; 50(11):1760-9. PubMed ID: 19837757
[TBL] [Abstract][Full Text] [Related]
37. Characteristics of Smoothing Filters to Achieve the Guideline Recommended Positron Emission Tomography Image without Harmonization.
Tsutsui Y; Awamoto S; Himuro K; Umezu Y; Baba S; Sasaki M
Asia Ocean J Nucl Med Biol; 2018; 6(1):15-23. PubMed ID: 29333463
[TBL] [Abstract][Full Text] [Related]
38. Quantitative PET/CT scanner performance characterization based upon the society of nuclear medicine and molecular imaging clinical trials network oncology clinical simulator phantom.
Sunderland JJ; Christian PE
J Nucl Med; 2015 Jan; 56(1):145-52. PubMed ID: 25525180
[TBL] [Abstract][Full Text] [Related]
39. Factors affecting standardized uptake value (SUV) of positron emission tomography (PET) imaging with l8F-FDG.
Wiyaporn K; Tocharoenchai C; Pusuwan P; Ekjeen T; Leaungwutiwong S; Thanyarak S
J Med Assoc Thai; 2010 Jan; 93(1):108-14. PubMed ID: 20196419
[TBL] [Abstract][Full Text] [Related]
40. Prognostic value of total lesion glycolysis by 18F-FDG PET/CT in surgically resected stage IA non-small cell lung cancer.
Park SY; Cho A; Yu WS; Lee CY; Lee JG; Kim DJ; Chung KY
J Nucl Med; 2015 Jan; 56(1):45-9. PubMed ID: 25525185
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
